An open-label, multicenter phase II trial of sunitinib for patients with chemorefractory metastatic gastric cancer.

被引：2
|
作者：
Moehler, M. H.
Hartmann, J. T.
Lordick, F.
Al-Batran, S.
Reimer, P.
Trarbach, T.
Ebert, M. P.
Daum, S.
Weihrauch, M.
Galle, P. R.
机构：
[1] Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany
[2] Christian Albrechts Univ Kiel Klinikum, Kiel, Germany
[3] Klinikum Braunschweig, Med Dept 3, Braunschweig, Germany
[4] Krankenhaus NW Frankfurt, Frankfurt, Germany
[5] Kliniken Essen Sued, Essen, Germany
[6] Univ Duisburg Essen, Dept Med, West German Canc Ctr, Essen, Germany
[7] Tech Univ Munich, Klinikum Rechts Isar, Med Dept 2, D-80290 Munich, Germany
[8] Charite, Berlin, Germany
[9] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14503
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14503
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Camrelizumab plus famitinib in patients with metastatic colorectal cancer: Results from an open-label, multicenter phase II basket study.
    Liu, Tianshu
    Yang, Mudan
    Li, Jin
    Pan, Yueyin
    Yuan, Ying
    Yi, Shanyong
    Wang, Junsheng
    Cheng, Ying
    Feng, Jifeng
    Gao, Shegan
    Wang, Xicheng
    Qu, Song
    Zhang, Xizhi
    Lu, Jin
    Xiu, Peng
    Wang, Shuni
    Yang, Xinfeng
    Fan, Jia
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [42] Open-label, multicenter, phase II trial of ABI-007 in previously treated and previously untreated patients with metastatic malignant melanoma.
    Hersh, EM
    O'Day, S
    Gonzalez, R
    Samlowski, WE
    Gordon, MS
    Hawkins, MJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 724S - 724S
  • [43] Phase II open label trial of Minnelide™ in patients with chemotherapy refractory metastatic pancreatic cancer
    Propper, David
    Borazanci, Erkut
    O'Dwyer, Peter J.
    Von Hoff, Daniel
    Hartlebury, Joseph
    Antal, Corina E.
    Evan, Gerard I.
    Han, HaiYong
    Downes, Michael
    Evans, Ronald
    Rabinowitz, Joshua
    Petricoin, Emmanuel
    Saluja, Ashok
    Velagapudi, Mohana
    Patel, Hitendra
    CANCER RESEARCH, 2024, 84 (07)
  • [44] Phase II open label trial of minnelide™ in patients with chemotherapy refractory metastatic pancreatic cancer
    Propper, David
    Han, Haiyong
    Von Hoff, Daniel
    Borazanci, Erkut
    Reya, Tannishtha
    Ghergurovich, Jonathan
    Pshenichnaya, Irina
    Antal, Corina
    Condjella, Rachel
    Sharma, Shreya
    O'Dwyer, Peter
    Littlewood, Trevor
    Patel, Hitendra
    Saluja, Ashok
    Velagapudi, Mohana
    Yang, Lifeng
    Downes, Michael
    Evans, Ronald
    Evan, Gerard
    CANCER RESEARCH, 2019, 79 (13)
  • [45] Phase II, prospective, open-label study of a weekly schedule of irinotecan in patients with advanced colorectal cancer.
    Casinello, J
    Dorta, J
    Aguiar, J
    Pérez-Carrión, J
    Castellanos, J
    Valladares, J
    Sevilla, J
    Belón, J
    Fernández, J
    Casal, J
    ANNALS OF ONCOLOGY, 2000, 11 : 46 - 46
  • [46] Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial
    Melisi, Davide
    Zecchetto, Camilla
    Merz, Valeria
    Malleo, Giuseppe
    Landoni, Luca
    Quinzii, Alberto
    Casalino, Simona
    Fazzini, Federica
    Gaule, Marina
    Pesoni, Camilla
    Casetti, Luca
    Esposito, Alessandro
    Marchegiani, Giovanni
    Piazzola, Cristiana
    D'Onofrio, Mirko
    de Robertis, Riccardo
    Gabbrielli, Armando
    Bernardoni, Laura
    Crino, Stefano F.
    Pietrobono, Silvia
    Luchini, Claudio
    Aliberti, Camillo
    Martignoni, Guido
    Milleri, Stefano
    Butturini, Giovanni
    Scarpa, Aldo
    Salvia, Roberto
    Bassi, Claudio
    EUROPEAN JOURNAL OF CANCER, 2024, 196
  • [47] A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
    Hasegawa, Hirotaka
    Shitara, Kohei
    Takiguchi, Shuji
    Takiguchi, Noriaki
    Ito, Seiji
    Kochi, Mitsugu
    Horinouchi, Hidehito
    Kinoshita, Takahiro
    Yoshikawa, Takaki
    Muro, Kei
    Nishikawa, Hiroyoshi
    Suna, Hideaki
    Kodera, Yasuhiro
    GASTRIC CANCER, 2022, 25 (03) : 619 - 628
  • [48] A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
    Hirotaka Hasegawa
    Kohei Shitara
    Shuji Takiguchi
    Noriaki Takiguchi
    Seiji Ito
    Mitsugu Kochi
    Hidehito Horinouchi
    Takahiro Kinoshita
    Takaki Yoshikawa
    Kei Muro
    Hiroyoshi Nishikawa
    Hideaki Suna
    Yasuhiro Kodera
    Gastric Cancer, 2022, 25 : 619 - 628
  • [49] A Phase II open-label study of capecitabine in combination with irinotecan as first-line treatment for metastatic colorectal cancer.
    Cartwright, TH
    Lopez, T
    Vukelja, SJ
    Encarnacion, C
    Boehm, KA
    Asmar, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 284S - 284S
  • [50] Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
    Lan, Chunyan
    Shen, Jingxian
    Wang, Yin
    Li, Jundong
    Liu, Zhimin
    He, Mian
    Cao, Xinping
    Ling, Jiayu
    Huang, Jiaming
    Zheng, Min
    Zou, Guorong
    Yan, Haowen
    Liu, Qing
    Yang, Fan
    Wei, Wei
    Deng, Yanhong
    Xiong, Ying
    Huang, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (34)
12345